Member Info for Scinv_temp

RNS says 13 patients

I don't think they would announce groundbreaking results in a poster that is not even presented by the CEO but here's hoping

🤣🤣🤣

Thanks, I guess I got confused. So we should see the same amount of buys today?

Excuse my ignorance mp, but don't the need to wait 30 days until they buy back? How is selling low helpful to them?

So clearly they don't expect the pps to rise in the next 30 days, if it is in fact bed & ISA

So clearly they don't expect the pps to rise in the next 30 days, if it is bed & ISA

That was years ago. Surely you don't think that's what they expected when they invested or that SC is treating them the same way it does us fools (retail investors)?

The funny thing is, you seem happy about that, so I have to ask, are you really invested here? Or are your motives different that what you try to project (you see that silly game that you like works both ways)?

TF, maybe you should ask someone over at SNG what happens when people only focus superficially on the science and then shoo away other holders who may not be as bullish as themselves. I think I've seen BOJO actually at that board, years ago. Perhaps he can tell you.

It is people who don't understand that investors have every right to question whatever they see fit who are irrational imho.

And by the way, since you are the one who used it as an argument, why are you now asking someone else to explain it?

Because you are full of poo poo :)

Lmao. OK. Got it now. Good luck with that attitude.

As I have signed many CDAs over the years I can tell you that this is not the case. What the other party might want is avoiding disclosure that they are interested, they cannot prevent scancell from communicating their own data. That only happens if they have pre agreed terms, nothing to do with CDA/NDA. And it's too early according to company.

Again, since you are sooooo good at getting replies, why don't you ask them this:

Scope open label study passed onto stage 2 with the data that were presented in September 2023. Two months later you provided an update on scope, shortly before the capital raise. Why haven't you updated investors since?

"prejudicing commercial discussions".

This is hilarious. How *exactly* updating on an open label study is "prejudicing commercial discussions"? The only time this happens is when thry already have a good deal that is conditional upon future data and the partner (buyer) has insisted that they don't publicly disclose until final, at which point the deal moves forward as pre agreed.

Except scancell already said it is too early for a deal and that should happen as we approach the phase 3 part of the next phase2/3 trial.

You use nonsense about food or fishing or whatever that I've seen so many times in these forums. That's how one gets hurt. Get real.

Final, I promise Because I'm allergic to BS. This is what the CEO said in the placing RNS (before the actual placing):

"Commenting on the proposed Capital Raise, Prof Lindy Durrant, Chief Executive Officer, said: “Scancell is producing highly-significant data across its pipeline of cancer vaccines. The recent updates from the SCOPE study are showing previously unseen response rates in melanoma including an objective response rate of over 85 per cent. and a complete responder. The study remains on track with data expected in H1 2024 and based upon the first 13 patients there is a greater than 90% probability that the second phase will also be successful."

H1 2024, so that "Q3" is not very consistent guidance, is it?

In fact it is quite recent.

(OK I'm done)

One last thing. I went back and checked the RNSs. September 2023, they reported on 11 patients and that they succesfully completed stage 1 of the trial (since then we are in Simon's stage 2). 2 months afterwards, they reported on 13 patients while the trial had already progressed to stage 2, then then they did the placing and then they said no more updates. These are the facts. Again, have a nice day.

The final data, yes. I am talking about an update, like the did end of '23 just before they asked for money. The CEO basically said no more updates (after they got the money of course) until data is (almost) final. And you are supposed to be an investor who looks after their capital? I'll leave it here. Have a nice day.

And a good investment can be tracked, but you need data for that, even if incomplete :) Maybe invest in a restaurant chain instead? Because this kind of attitude is how people lose their capital. How about sending them an email? I have, and they have not replied. Can you do it better?

Well, you got nothing so far 🤷‍♀️

Yet they didn't mind updating us end of 2023 with incomplete data when they had already presented incomplete data in September or October 2023, because they needed money. Once they got it, they decided to poop on the people who provided and just talk to everyone else. A small company I know, but it is not too complex to throw investors a bone, is it?

🤣🤣🤣🤣